Vifor Consumer Health to become Verfora

Tuesday, 13 March 2018

From mid-2018, Verfora will be the new name for Vifor Consumer Health, a company of the Galenica Group.

The company’s strategy will not change, and Verfora will remain a strong partner for pharmacies and drug stores in future, offering an attractive product portfolio and subject-specific training.

The name Verfora is made up of the Latin words “veritas” (truth) and “forum”. On the one hand, Verfora conveys just how important objectivity, medical evidence and integrity are to the company in all of its relationships and activities and, on the other, underlines its strong belief in active dialogue between healthcare professionals and their patients and consumers.

Clear positioning after the Galenica Group’s IPO

What is today the Galenica Group was floated on the Swiss stock exchange SIX as an independent company in an IPO in spring 2017 by its then parent company, which is now Vifor Pharma Ltd. Galenica and Vifor Pharma agreed that Vifor Consumer Health would change its’ name.

The company will therefore trade as Verfora from mid-2018. This will clearly underline the separation from Vifor Pharma on the market and the new name will allow Verfora to achieve an even better position as an independent, strong specialist retail partner with a portfolio of well-known brands.

Verfora – a strong partner for pharmacies and drug stores

The new name and brand identity will not change the company’s strategy. Verfora will remain a strongpartner for pharmacies and drug stores in future offering an attractive product portfolio, specialist services and training.

As the rights or licence holder to pharmaceutical products, Vifor Consumer Health AG will trade under the name Verfora AG from mid-2018. The brand name has been changed accordingly from Vifor to Verfora.


Galenica Ltd.

Untermattweg 8
3027 Bern

Tel. +41 58 852 85 17
Mobile +41 79 371 77 24
Fax +41 58 852 85 58